Patent Assignment
Reel/Frame 064365/0804
Change of Name
Recorded: 2023-07-24
Pages: 4
Assignor
SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Executed: 2022-04-01
Assignee
SUMITOMO PHARMA ONCOLOGY, INC.
84 WATERFORD DRIVE, MARLBOROUGH, MASSACHUSETTS, 01752
Covered Property
(1)
Forms and Formulations Of A Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitor
Application:
18/260,170 →
Publication:
US 2024/0091226
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.